| 1 | infections in pregnancyprevention of | | | | | | | 2 | 0.59% |
| 2 | in pregnancyprevention of perinatal | | | | | | | 2 | 0.59% |
| 3 | pregnancyprevention of perinatal infection | | | | | | | 2 | 0.59% |
| 4 | antibioticsantimicrobial spectrum of activity | | | | | | | 2 | 0.59% |
| 5 | dosing guide and daily | | | | | | | 2 | 0.59% |
| 6 | home antibiotics treatment prophylaxis | | | | | | | 1 | 0.30% |
| 7 | joint osteomyelitis contiguous vascular insufficiency diabetic | | | | | | | 1 | 0.30% |
| 8 | antibiotics antimicrobial spectrum of activity antifungals | | | | | | | 1 | 0.30% |
| 9 | antibiotics csf penetration of antimicrobials antimicrobial | | | | | | | 1 | 0.30% |
| 10 | penetration into cerebrospinal fluid | | | | | | | 1 | 0.30% |
| 11 | into cerebrospinal fluid csf antifungals | | | | | | | 1 | 0.30% |
| 12 | cerebrospinal fluid csf antifungals treatment | | | | | | | 1 | 0.30% |
| 13 | recommendations adult patients skinsoft tissue diabetic foot | | | | | | 1 | 0.30% |
| 14 | infection dfi treatment recommendations adult | | | | | | | 1 | 0.30% |
| 15 | dfi treatment recommendations adult patients bone | | | | | | | 1 | 0.30% |
| 16 | september 2023 treatment recommendationscentral | | | | | | | 1 | 0.30% |
| 17 | foot updated september 2023 | | | | | | 1 | 0.30% |
| 18 | updated september 2023 treatment | | | | | | | 1 | 0.30% |
| 19 | aspiration updated october 2023 | | | | | | | 1 | 0.30% |
| 20 | 2023 treatment recommendationscentral nervous | | | | | | | 1 | 0.30% |
| 21 | systembrain abscess neonatespaediatric patients | | | | | | | 1 | 0.30% |
| 22 | abscess neonatespaediatric patients adult | | | | | | | 1 | 0.30% |
| 23 | neonatespaediatric patients adult patients | | | | | | | 1 | 0.30% |
| 24 | treatment recommendationsadult patientsgenitalscabies treatment | | | | | | | 1 | 0.30% |
| 25 | tissue scabies treatment recommendationsadult patientssepsis | | | | | | | 1 | 0.30% |
| 26 | urosepsispyelonephritis treatment recommendationsadult patientsurinary | | | | | | | 1 | 0.30% |
| 27 | antibiotics treatment prophylaxis dental | | | | | | | 1 | 0.30% |
| 28 | impairment antituberculous agents treatment recommendationsadult | | | | | | | 1 | 0.30% |
| 29 | pneumonia aspiration updated october | | | | | | | 1 | 0.30% |
| 30 | november 2023 treatment recommendationsculturedirected | | | | | | | 1 | 0.30% |
| 31 | updated january 2024 treatment | | | | | | | 1 | 0.30% |
| 32 | recommendationsophthalmic infections endophthalmitis treatment | | | | | | | 1 | 0.30% |
| 33 | of perinatal infection antimicrobial | | | | | | | 1 | 0.30% |
| 34 | prophylaxis for preterm37 weeks | | | | | | | 1 | 0.30% |
| 35 | for preterm37 weeks gestation | | | | | | | 1 | 0.30% |
| 36 | preterm37 weeks gestation rupture | | | | | | | 1 | 0.30% |
| 37 | weeks gestation rupture of | | | | | | | 1 | 0.30% |
| 38 | gestation rupture of membranes | | | | | | | 1 | 0.30% |
| 39 | rupture of membranes updated | | | | | | | 1 | 0.30% |
| 40 | 2023 treatment recommendationsculturedirected infections | | | | | | | 1 | 0.30% |